Laboratory support for analyses of human CSF and plasma, on NIA protocol 10-AG-0423: a clinical trial of exendin-4 for the treatment of alzheimer's disease, for the national institute on aging…
Ended Purchase Order Awarded Last action
- Contract number
- HHSN271201500002P
- Awardee
-
The Trustees Of The University Of Pennsylvania UEI GM1XX56LEP58
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,412
Award facts
- Contract value 100% obligated
- $6,412.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Heart Lung and Blood Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$458 | |
| Original award | $6,870 |
About this award
This is a purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the Department of Health and Human Services, to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The $6,870 firm-fixed-price contract is for laboratory support services to analyze human cerebrospinal fluid and plasma samples from a National Institute on Aging (NIA) clinical trial evaluating the use of exenatide (Exendin-4) for the treatment of Alzheimer's disease. The contract did not utilize a set-aside designation. The period of performance is from October 16, 2014 through October 15, 2015, with a stated ultimate completion date of February 25, 2020. The University of Pennsylvania is a renowned private research institution with extensive expertise in biomedical sciences that frequently conducts research and provides services to federal agencies through contracts and grants.
Description
Laboratory support for analyses of human CSF and plasma, on NIA protocol 10-AG-0423: a clinical trial of exendin-4 for the treatment of alzheimer's disease, for the national institute on aging (NIA). The contracting officer s representative (COR) is patricia duffey, head, protocols, special projects and regulatory unit, laboratory of clinical investigation, intramural research program (IRP), NIA, 410-350-3935. The attached statement of work is effective for the period of performance from october 16, 2014 through october 15, 2015 applicable to this order. The total ceiling value of this purchase order is $6,870. Clause at far 52.213-4 contract terms and conditions -- simplified acquisitions (other than commercial items) (july 2014), applies to this order and is incorporated as an attachment.
Quick answers
Who was awarded contract HHSN271201500002P?
HHSN271201500002P was awarded to The Trustees Of The University Of Pennsylvania by National Institute on Drug Abuse (National Institutes of Health) on October 16, 2014.
How much is contract HHSN271201500002P worth?
The government has obligated $6,412 on HHSN271201500002P.
Which agency awarded contract HHSN271201500002P?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201500002P, with funding from National Heart Lung and Blood Institute (National Institutes of Health).
Was contract HHSN271201500002P competed?
The extent of competition for HHSN271201500002P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award